Healthcare -
Biotechnology - NASDAQ - US
$ 3.12
-8.5 %
$ 529 M
Market Cap
-1.32
P/E
RLAY - GROSS PROFIT
Gross Profit RLAY - Relay Therapeutics, Inc.
20.3 M
LAST VALUE
396.29%
2 YEAR CAGR
62.74%
5 YEAR CAGR
0.00%
10 YEAR CAGR